Necrosis targeted combinational theragnostic approach to treat cancer

Residual cancer cells and subsequent tumor relapse is an obstacle for curative cancer treatment. Tumor necrosis therapy (TNT) has recently been developed to cause residual tumor regression or destruction. Here, we exploited the avidity of the sennidin A (SA) tracer and radioiodinated SA ((131)I-SA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Yun, Jiang, Cuihua, Zhang, Xueli, Liu, Wei, Gao, Meng, Li, Yue, Wang, Junhu, Wang, Qingqing, Sun, Ziping, Jiang, Xiao, Yao, Nan, Wang, Xiaoning, Fang, Zhijun, Yin, Zhiqi, Ni, Yicheng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102781/
https://www.ncbi.nlm.nih.gov/pubmed/24931286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102781/
https://www.ncbi.nlm.nih.gov/pubmed/24931286

Ejemplares similares